Syngen Biotech Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Syngen Biotech Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores

Secondary Activities: Medical Equipment and Supplies Manufacturing | Used Merchandise Stores | Other Miscellaneous Store Retailers | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Convention and Trade Show Organizers | All Other Miscellaneous Schools and Instruction | Electronic and Precision Equipment Repair and Maintenance

Full name: Syngen Biotech Sp. z o.o.

Profile Updated: May 26, 2024

Syngen Biotech Sp. z o.o. is a company based in Poland, with its head office in Wroclaw. The company operates in the Pharmacies and Drug Stores industry. It was established on July 18, 2022. The latest financial highlights indicate a net sales revenue drop of 19.11% in 2023. Its’ total assets recorded a growth of 25.08%. In 2023, Syngen Biotech Sp. z o.o.’s net profit margin increased by 4.32%.

Headquarters
Ul. Ostrodzka 13
Wroclaw; Dolnoslaskie; Postal Code: 54-116

Contact Details: Purchase the Syngen Biotech Sp. z o.o. report to view the information.

Website: http://www.syngen.pl

Basic Information

Outstanding Shares:

Purchase the Syngen Biotech Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Syngen Biotech Sp. z o.o. report to view the information.

Incorporation Date:

July 18, 2022

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

99%

Company Performance

Financial values in the chart are available after Syngen Biotech Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-19.11%▼

Total operating revenue

-19.41%▼

Operating profit (EBIT)

-1.37%▼

EBITDA

-3.91%▼

Net Profit (Loss) for the Period

3.01%▲

Total assets

25.08%▲

Total equity

26.9%▲

Operating Profit Margin (ROS)

4.72%▲

Net Profit Margin

4.32%▲

Return on Equity (ROE)

-4.92%▼

Quick Ratio

9.77%▲

Cash Ratio

7.9%▲

Similar companies